{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:31:51Z","timestamp":1791297111469,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.vaccine.2013.12.011","type":"journal-article","created":{"date-parts":[[2013,12,25]],"date-time":"2013-12-25T10:30:15Z","timestamp":1387967415000},"page":"645-650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination"],"prefix":"10.1016","volume":"32","author":[{"given":"Tania","family":"Schink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Holstiege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Kowalzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Zepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edeltraut","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"47","key":"10.1016\/j.vaccine.2013.12.011_bib0005","first-page":"1212","article-title":"Notice to readers: licensure of a combined live attenuated measles, mumps, rubella, and varicella vaccine","volume":"54","author":"CDC","year":"2005","journal-title":"MMWR"},{"issue":"34","key":"10.1016\/j.vaccine.2013.12.011_bib0010","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1016\/j.vaccine.2009.05.056","article-title":"Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting","volume":"27","author":"Jacobsen","year":"2009","journal-title":"Vaccine"},{"issue":"47","key":"10.1016\/j.vaccine.2013.12.011_bib0015","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1016\/j.vaccine.2009.07.076","article-title":"A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): immunogenicity and safety profile","volume":"27","author":"Czajka","year":"2009","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2013.12.011_bib0020","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1016\/j.vaccine.2011.02.067","article-title":"Immunogenicity and safety of a measles-mumps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses","volume":"29","author":"Rumke","year":"2011","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2013.12.011_bib0025","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.inf.0000172902.25009.a1","article-title":"Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children","volume":"24","author":"Shinefield","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2013.12.011_bib0030","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2010-0665","article-title":"Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures","volume":"126","author":"Klein","year":"2010","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2013.12.011_bib0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4161\/hv.2.5.3246","article-title":"Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad)","volume":"2","author":"Kuter","year":"2006","journal-title":"Hum Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2013.12.011_bib0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/pds.1545","article-title":"Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations","volume":"17","author":"Pigeot","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2013.12.011_bib0045","first-page":"S294","article-title":"Representativity of dispensations of non-steroidal anti-inflammatory drugs (NSAIDs) in the German Pharmacoepidemiological Research Database","volume":"19","author":"Schink","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2013.12.011_bib0050","first-page":"S178","article-title":"Assessment of the representativity of in-patient hospital diagnoses in the German Pharmacoepidemiological Research Database","volume":"19","author":"Schink","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2013.12.011_bib0055","series-title":"Allgemeine und spezielle Kodierrichtlinien f\u00fcr die Verschl\u00fcsselung von Krankheiten und Prozeduren [German Coding Guidelines 2007. General and specific coding guidelines for coding of diseases and procedures]","first-page":"163","author":"InEK gGmbH. Deutsche Kodierrichtlinien 2007","year":"2006"},{"key":"10.1016\/j.vaccine.2013.12.011_bib0060","series-title":"Design strategies to improve study accuracy. Modern epidemiology","first-page":"168","author":"Rothman","year":"2008"},{"key":"10.1016\/j.vaccine.2013.12.011_bib0065","series-title":"GlaxoSmithKline. Integrated Summary Output (ISO) on febrile convulsions","year":"2011"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2013.12.011_bib0070","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0264-410X(02)00459-0","article-title":"Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine","volume":"21","author":"Nolan","year":"2002","journal-title":"Vaccine"},{"issue":"4\u20136","key":"10.1016\/j.vaccine.2013.12.011_bib0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000110928","article-title":"Incidence of febrile seizures in The Netherlands","volume":"11","author":"Verburgh","year":"1992","journal-title":"Neuroepidemiology"},{"issue":"37","key":"10.1016\/j.vaccine.2013.12.011_bib0080","first-page":"26","article-title":"[Infants and young children with fever of unknown origin. Systematic procedure based on a diagnosis-therapy diagram]","volume":"141","author":"Muschenborn-Koglin","year":"1999","journal-title":"MMW Fortschr Med"},{"key":"10.1016\/j.vaccine.2013.12.011_bib0085","series-title":"Validity in epidemiologic studies. Modern epidemiology","first-page":"128","author":"Rothman","year":"2008"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2013.12.011_bib0090","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00103-007-0248-0","article-title":"Durchimpfung und Determinanten des Impfstatus in Deutschland. Ergebnisse des Kinder- und Jugendgesundheitssurveys (KiGGS)","volume":"50","author":"Poethko-Muller","year":"2007","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"11","key":"10.1016\/j.vaccine.2013.12.011_bib0095","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00103-009-0952-z","article-title":"\u00dcberblick und Bewertung der verf\u00fcgbaren Datenquellen zur Inzidenz impfpr\u00e4ventabler Krankheiten, zum Durchimpfungsgrad und zum Immunstatus","volume":"52","author":"Poggensee","year":"2009","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13017428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13017428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T16:57:39Z","timestamp":1538931459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13017428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0264410X13017428"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}